AVIR - Atea Pharmaceuticals Q3 2022 Earnings Preview
- Atea Pharmaceuticals ( NASDAQ: AVIR ) is scheduled to announce Q3 earnings results on Monday, November 7th, before market open.
- The consensus EPS Estimate is -$0.44 (-29.4% Y/Y) and the consensus Revenue Estimate is $0M
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 0 downward.
For further details see:
Atea Pharmaceuticals Q3 2022 Earnings Preview